Clinically, CBS patients carrying C9orf72 mutations demonstrate more severe cognitive impairment, frequently presenting with a frontal dysexecutive syndrome, attention deficits, and behavioral symptoms such as apathy, disinhibition, mutism, ritualistic behaviors, and hyperphagia, compared to non-carriers. Here, CBS is linked to Cognitive impairment.